Vinay Prasad is taking on several big roles at the FDA, solidifying his position as a top adviser to Commissioner Marty ...

Shares of gene editing companies were largely steady in the premarket on Friday after the FDA’s Center for Biologics Research ...

Vinay Prasad, the FDA’s freshly appointed head of vaccines, has been named chief medical and scientific officer, taking on ...

FDA Commissioner Marty Makary has told staff that Center for Biologics Evaluation and Research Director Vinay Prasad has been ...

The reported dismissal of high-ranking CBER officials Nicole Verdun and Rachael Anatol resurfaced lingering concerns about how gene therapies will be regulated under new FDA leadership.

"For more than 40 years, NORD has driven progress in rare disease science by fostering collaboration ... the newly appointed FDA CBER Director. More than 20 expert-led sessions exploring ...

most recently as senior adviser for translational science, would serve as acting director of CBER, according to a memo obtained by NBC News. Berkeley Lovelace Jr. Berkeley Lovelace Jr. is a health ...

Steele also served as a White House adviser on science and technology under George W. Bush, Reuters reported this week. The acting director is slated to lead CBER at a tumultuous moment for the ...

Regulatory Expectations Under Makary-Prasad-Jain Leadership Under Commissioner Makary's and CBER Director ... to be agile – focusing on high-quality science to thrive under tougher standards ...

Bengaluru: The U.S. Food and Drug Administration (USFDA) top vaccine official, Vinay Prasad, has been appointed as the agency ...